BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mashek DG. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD. Mol Metab 2021;50:101115. [PMID: 33186758 DOI: 10.1016/j.molmet.2020.101115] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Dibwe DF, Oba S, Takeishi N, Sakurai T, Tsukui T, Chiba H, Hui S. Food-Derived β-Carboline Alkaloids Ameliorate Lipid Droplet Accumulation in Human Hepatocytes. Pharmaceuticals 2022;15:578. [DOI: 10.3390/ph15050578] [Reference Citation Analysis]
2 Wang T, Ye Y, Ji J, Zhang S, Yang X, Xu J, Wang JS, Chen Z, Xia B, Shen H, Xia R, Shi W, Sun X. Astilbin from Smilax glabra Roxb. alleviates high-fat diet-induced metabolic dysfunction. Food Funct 2022;13:5023-36. [PMID: 35388843 DOI: 10.1039/d2fo00060a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Santos-Baez LS, Ginsberg HN. Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides. Curr Opin Lipidol 2021;32:200-6. [PMID: 33883445 DOI: 10.1097/MOL.0000000000000756] [Reference Citation Analysis]
4 Wei WF, Sun H, Liu SB, Lu SW, Zhang AH, Wang WY, Chai WJ, Wu FF, Yan GL, Guan Y, Wang XJ. Targets and Effective Constituents of ZhiziBaipi Decoction for Treating Damp-Heat Jaundice Syndrome Based on Chinmedomics Coupled with UPLC-MS/MS. Front Pharmacol 2022;13:857361. [PMID: 35450037 DOI: 10.3389/fphar.2022.857361] [Reference Citation Analysis]
5 Henderson GC, Meyer JM. Transient elevation of triacylglycerol content in the liver: a fundamental component of the acute response to exercise. Journal of Applied Physiology 2021;130:1293-303. [DOI: 10.1152/japplphysiol.00930.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Griffin JD, Bejarano E, Wang XD, Greenberg AS. Integrated Action of Autophagy and Adipose Tissue Triglyceride Lipase Ameliorates Diet-Induced Hepatic Steatosis in Liver-Specific PLIN2 Knockout Mice. Cells 2021;10:1016. [PMID: 33923083 DOI: 10.3390/cells10051016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Qian Q, Li Y, Fu J, Leng D, Dong Z, Shi J, Shi H, Cao D, Cheng X, Hu Y, Luo Q, Hu M, Ran Y, Tang H, Liu H, Liu J. Switch-associated protein 70 protects against nonalcoholic fatty liver disease through suppression of TAK1. Hepatology 2022;75:1507-22. [PMID: 34689362 DOI: 10.1002/hep.32213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li H, Dun Y, Zhang W, You B, Liu Y, Fu S, Qiu L, Cheng J, Ripley-Gonzalez JW, Liu S. Exercise improves lipid droplet metabolism disorder through activation of AMPK-mediated lipophagy in NAFLD. Life Sci 2021;273:119314. [PMID: 33667513 DOI: 10.1016/j.lfs.2021.119314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang G, Han J, Wang L, Yang X, Yan Z, Qu M, Zhou H, Bilal H, Wang F, Ge H, Yang X. The vesicular transporter STX11 governs ATGL-mediated hepatic lipolysis and lipophagy. iScience 2022;25:104085. [DOI: 10.1016/j.isci.2022.104085] [Reference Citation Analysis]
10 Mahlapuu M, Caputo M, Xia Y, Cansby E. GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond. Hepatol Commun 2022. [PMID: 35641240 DOI: 10.1002/hep4.2013] [Reference Citation Analysis]
11 Ogino N, Miyagawa K, Nagaoka K, Sumida K, Kusanaga M, Oe S, Honma Y, Shibata M, Harada M, Suganuma N, Ogino K. Airborne fine particulate matter in Japan induces lipid synthesis and inhibits autophagy in HepG2 cells. Int J Biochem Cell Biol 2021;141:106099. [PMID: 34673217 DOI: 10.1016/j.biocel.2021.106099] [Reference Citation Analysis]
12 Henderson GC. Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease. Nutrients 2021;13:2590. [PMID: 34444750 DOI: 10.3390/nu13082590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhao WJ, Bian YP, Wang QH, Yin F, Yin L, Zhang YL, Liu JH. Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress. Acta Pharmacol Sin 2022;43:645-58. [PMID: 33990765 DOI: 10.1038/s41401-021-00681-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
14 Lee HW, Lee IJ, Lee SJ, Kim YR, Kim HM. Highly Sensitive Two-Photon Lipid Droplet Tracker for In Vivo Screening of Drug Induced Liver Injury. ACS Sens 2022;7:1027-35. [PMID: 35385270 DOI: 10.1021/acssensors.1c02679] [Reference Citation Analysis]
15 Zhou H, Zhu X, Yao Y, Su Y, Xie J, Zhu M, He C, Ding J, Xu Y, Shan R, Wang Y, Zhao X, Ding Y, Liu B, Shao Z, Liu Y, Xu T, Xie Y. TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/β-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease. Front Pharmacol 2021;12:798735. [PMID: 35058782 DOI: 10.3389/fphar.2021.798735] [Reference Citation Analysis]
16 Passos E, Pereira C, Gonçalves IO, Faria A, Ascensão A, Monteiro R, Magalhães J, Martins MJ. Physical exercise positively modulates nonalcoholic steatohepatitis-related hepatic endoplasmic reticulum stress. J Cell Biochem 2022. [PMID: 35467032 DOI: 10.1002/jcb.30250] [Reference Citation Analysis]
17 Ferri F, Carotti S, Carpino G, Mischitelli M, Cantafora A, Molinaro A, Argenziano ME, Parisse S, Corsi A, Riminucci M, Lai Q, Mennini G, Spadetta G, Pugliese F, Rossi M, Morini S, Gaudio E, Ginanni Corradini S. The Propensity of the Human Liver to Form Large Lipid Droplets Is Associated with PNPLA3 Polymorphism, Reduced INSIG1 and NPC1L1 Expression and Increased Fibrogenetic Capacity. Int J Mol Sci 2021;22:6100. [PMID: 34198853 DOI: 10.3390/ijms22116100] [Reference Citation Analysis]
18 Chang BY, Kim HJ, Kim TY, Kim SY. Enzyme-Treated Zizania latifolia Extract Protects against Alcohol-Induced Liver Injury by Regulating the NRF2 Pathway. Antioxidants (Basel) 2021;10:960. [PMID: 34203789 DOI: 10.3390/antiox10060960] [Reference Citation Analysis]
19 Cao Y, Shi J, Song L, Xu J, Lu H, Sun J, Hou J, Chen J, Wu W, Gong L. Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie–Baizhu Decoction. Front Pharmacol 2022;13:858795. [DOI: 10.3389/fphar.2022.858795] [Reference Citation Analysis]
20 Li HY, Peng ZG. Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease. Biochem Pharmacol 2022;197:114933. [PMID: 35093393 DOI: 10.1016/j.bcp.2022.114933] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hu B, Yang H, Chen G, Sun X, Zou X, Ma J, Yao X, Liang Q, Liu H. Structural characterization and preventive effect on non-alcoholic fatty liver disease of oligosaccharides from Bletilla striata. Food Funct 2022;13:4757-69. [PMID: 35389416 DOI: 10.1039/d1fo03899k] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Murakami K, Sasaki Y, Asahiyama M, Yano W, Takizawa T, Kamiya W, Matsumura Y, Anai M, Osawa T, Fruchart JC, Fruchart-Najib J, Aburatani H, Sakai J, Kodama T, Tanaka T. Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis. Cells 2022;11:720. [PMID: 35203369 DOI: 10.3390/cells11040720] [Reference Citation Analysis]
23 Nwakiban Atchan AP, Shivashankara ST, Piazza S, Tchamgoue AD, Beretta G, Dell'Agli M, Magni P, Agbor GA, Kuiaté JR, Manjappara UV. Polyphenol-Rich Extracts of Xylopia and Aframomum Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation in Diet-Induced Obese Mice. ACS Omega 2022;7:11914-28. [PMID: 35449947 DOI: 10.1021/acsomega.2c00050] [Reference Citation Analysis]
24 Kotlyarov S, Bulgakov A. Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. Cells 2021;10:2978. [PMID: 34831201 DOI: 10.3390/cells10112978] [Reference Citation Analysis]
25 Ishiyama S, Kimura M, Umihira N, Matsumoto S, Takahashi A, Nakagawa T, Wakayama T, Kishigami S, Mochizuki K. Consumption of barley ameliorates the diabetic steatohepatitis and reduces the high transforming growth factor β expression in mice grown in α-minimum essential medium in vitro as embryos. Biochem Biophys Rep 2021;27:101029. [PMID: 34136664 DOI: 10.1016/j.bbrep.2021.101029] [Reference Citation Analysis]